Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis

Synergy of Losartan and chemotherapy for patients with cholangiocarcinoma: A propensity score-matched analysis

BackgroundCholangiocarcinoma (CCA) is a malignant tumor originating from bile duct epithelial cells that no obvious clinical symptoms and specific clinical manifestations are shown in the early stage of CCA.MethodsPropensity score matching (PSM) is a quasi-experimental method in which this study use...

Full description

Bibliographic Details
Main Authors: Qing Li, Zhenyu Chang, Tianyi Wang, Bing Liu, Ximin Wang, Xin-Yu Ge, Tao Yang, Qu Liu, Wei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
Cholangio carcinoma
prognosis
PSM
losartan
chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.989080/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.989080/full

Similar Items